Michelle Melisko

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer”.

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2020.2535

N/A

6.3DataRank · unranked

225 citations

Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain +74 more

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03555-z

N/A

1.9DataRank · unranked

82 citations

Martin Fleisher, Priya Kumthekar, Xuling Lin, Antonio Omuro, Morris D. Groves +12 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z

N/A

0.900DataRank · unranked

27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer

Journal of the American Medical Informatics Association(2024)10.1093/jamia/ocae190

N/A

0.165DataRank · unranked

2 citations

Anika Christofferson, Saumya Umashankar, Michelle Melisko, Paolo Castillo, Thelma Brown +15 more

Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases

BMC Cancer(2025)10.1186/s12885-025-14282-x

N/A

0.112DataRank · unranked

1 citations

Paul M Harary, Thy Trinh, Monica Granucci, Sophie Bertrand, Brandon Carlson-Clarke +14 more

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

Nature Communications(2021)10.1038/s41467-021-26019-y

N/A

0DataRank · unranked

73 citations

Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, L. J. van ‘t Veer, Douglas Yee +46 more

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00337-2

N/A

0DataRank · unranked

29 citations

Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar +50 more

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

npj Breast Cancer(2021)10.1038/s41523-021-00366-x

N/A

0DataRank · unranked

24 citations

Amy M. Shui, Michelle Melisko, A. Jo Chien, Emi Yoshida, Elizabeth Lancaster +4 more

A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics

Neuro-Oncology(2022)10.1093/neuonc/noac195

N/A

0DataRank · unranked

82 citations

Michael J. Avram, Andrew B. Lassman, Nancy U. Lin, Eudocia Q. Lee, Sean Grimm +13 more

A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1076

N/A

0DataRank · unranked

19 citations

Amelia S. Gliwa, Siti Rahmaputri, H Dittrich, Melanie Majure, Hope S. Rugo +10 more

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256

N/A

0DataRank · unranked

20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

High-dimensional immune cell profiling of cerebrospinal fluid from patients with metastatic breast cancer and leptomeningeal disease

npj Breast Cancer(2023)10.1038/s41523-023-00526-1

N/A

0DataRank · unranked

7 citations

Laura A. Huppert, Lev Malevanchik, Hope S. Rugo, Alexis J. Combes, Michael J. Campbell +3 more

374P Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.552

N/A

0DataRank · unranked

1 citations

Saumya Umashankar, Muneeb M. Musthafa, Thomas Jones, Kasey Blevins, Timothy D. Brown +15 more

Use of PROMIS to capture patient reported outcomes over time for patients on I-SPY2.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.611

N/A

0DataRank · unranked

2 citations

Hongmei Yu, Denise M. Wolf, Nisha Acharya, Susie Brain, Carol A. Simmons +8 more

Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07339-1

N/A

0DataRank · unranked

6 citations

Samantha Fisch, Elene Tsopurashvili, Sai Sahitha Somepalle, Mia Salans, Harish N. Vasudevan +7 more

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

npj Breast Cancer(2025)10.1038/s41523-025-00748-5

N/A

0DataRank · unranked

39 citations

Reshma Mahtani, Samantha Fisch, Naomi Dempsey, Sarah Premji, Angelina Raimonde +17 more

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

UNC Libraries(2020)10.17615/bgrr-9v25

N/A

0DataRank · unranked

0 citations

Anna Maria Storniolo, Vered Stearns, Vandana G. Abramson, Joel S. Parker, Catherine Van Poznak +19 more

Evaluating survival trends over time in patients with metastatic breast cancer and brain metastases: a single center retrospective cohort study

Breast Cancer Research(2025)10.1186/s13058-025-02121-7

N/A

0DataRank · unranked

1 citations

Michelle Jayaraj, Mia Salans, Kelsey Kuwahara, Maggie H. Zhou, Samantha Fisch +12 more

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Cancer Cell(2021)10.1016/j.ccell.2021.05.009

N/A

0DataRank · unranked

335 citations

Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace +40 more